Skip to content

Contrast Ultrasound Perfusion Imaging in Peripheral Arterial Disease (PAD)

Contrast Ultrasound Perfusion Imaging in Peripheral Arterial Disease

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01377649
Enrollment
18
Registered
2011-06-21
Start date
2011-07-31
Completion date
2016-09-30
Last updated
2016-09-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Peripheral Arterial Disease

Brief summary

Contrast ultrasound is a technique that can quantify blood flow in the tissues of the body by ultrasound detection of microbubble contrast agents that behave in the circulation similar to red blood cells. In this study, the investigators hypothesize that contrast ultrasound of blood flow in the leg (thigh and calf) at rest and during stress produced by medications that mimic exercise (vasodilator stress) can provide information on the location and severity of peripheral vascular disease (blockages of the blood vessels in the leg). The investigators will also determine whether symptom improvement after revascularization (procedures to open up or bypass the blockages) is directly related to the improvement in blood flow.

Interventions

None listed

Sponsors

Oregon Health and Science University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
19 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

1. Known or suspected PAD 2. Lower extremity angiography or MRA planned or performed within 6 months

Exclusion criteria

1. Age \<19 y.o. 2. Pregnant or lactating females 3. Hypersensitivity to ultrasound contrast agent, dipyridamole, or regadenoson 4. Severe reactive airways disease 5. Evidence right-to-left shunt (identified on screening echo) 6. NYHA Class III or IV heart failure. 7. Planned amputation 8. Unstable coronary artery disease or severe aortic stenosis

Design outcomes

Primary

MeasureTime frameDescription
Quantitation of PerfusionImmediateCorrelation of skeletal muscle perfusion with symptom status

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026